Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 1.28
-1.56 %
$ 139 M
Market Cap
-0.75
P/E
ACRS - REVENUE
Revenue ACRS - Aclaris Therapeutics, Inc.
18.7 M
LAST VALUE
-20.68%
2 YEAR CAGR
34.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR